{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:01:46Z","timestamp":1789740106440,"version":"4.0.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007401","name":"Sri Ramachandra University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12769-9","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:06:14Z","timestamp":1789736774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial metabolite transporters at the crossroads of metabolic reprogramming, epigenetic regulation and therapeutic vulnerabilities in colorectal cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Kaviya","family":"S","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6569-5806","authenticated-orcid":false,"given":"Sumathy","family":"Arockiasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Satish","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundersingh","family":"Shirley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"12769_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/mco.2021.2433","volume":"6","author":"SM Alzahrani","year":"2021","unstructured":"Alzahrani SM, Al Doghaither HA, Al-Ghafari AB (2021) General insight into cancer: An overview of colorectal cancer (Review). Mol Clin Oncol 6:271. https:\/\/doi.org\/10.3892\/mco.2021.2433","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"12769_CR2","doi-asserted-by":"publisher","first-page":"e70090","DOI":"10.3322\/caac.70090","volume":"76","author":"H Sung","year":"2026","unstructured":"Sung H, Filho AM, Laversanne M, Ferlay J, Siegel RL, Soerjomataram I, Jemal A, Bray F (2026) Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin 76(4):e70090. https:\/\/doi.org\/10.3322\/caac.70090","journal-title":"CA Cancer J Clin"},{"key":"12769_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H et al (2024) Signalling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Sig Transduct Target Ther 9:266. https:\/\/doi.org\/10.1038\/s41392-024-01953-7","journal-title":"Sig Transduct Target Ther"},{"key":"12769_CR4","doi-asserted-by":"publisher","unstructured":"Vasan K, Werner M, Chandel NS (2020) Mitochondrial metabolism as a target for cancer therapy. Cell Metabol 341\u2009\u2013\u200952. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.019","DOI":"10.1016\/j.cmet.2020.06.019"},{"issue":"1","key":"12769_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40364-026-00898-z","volume":"14","author":"P Wu","year":"2026","unstructured":"Wu P, Zhang J, Jiang Z, Liu X, Jiang N, Zou J, Chen X, Wu D, Li Y (2026) Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications. Biomark Res 14(1):21. https:\/\/doi.org\/10.1186\/s40364-026-00898-z","journal-title":"Biomark Res"},{"issue":"1","key":"12769_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/ijms26010092","volume":"26","author":"A Ahmed","year":"2025","unstructured":"Ahmed A, Iaconisi GN, Di Molfetta D, Coppola V, Caponio A, Singh A, Bibi A, Capobianco L, Palmieri L, Dolce V, Fiermonte G (2025) The Role of Mitochondrial Solute Carriers SLC25 in Cancer Metabolic Reprogramming: Current Insights and Future Perspectives. Int J Mol Sci 26(1):92. https:\/\/doi.org\/10.3390\/ijms26010092","journal-title":"Int J Mol Sci"},{"key":"12769_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10602","volume":"481","author":"CM Metallo","year":"2012","unstructured":"Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, Jewell CM, Johnson ZR, Irvine DJ, Guarente L, Kelleher JK (2012) Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481:380\u2013384. https:\/\/doi.org\/10.1038\/nature10602","journal-title":"Nature"},{"key":"12769_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13046-016-0310-6","volume":"35","author":"HS Dorward","year":"2016","unstructured":"Dorward HS, Du A, Bruhn MA, Wrin J, Pei JV, Evdokiou A, Price TJ, Yool AJ, Hardingham JE (2016) Pharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitro. J Exp Clin Cancer Res 35:36. https:\/\/doi.org\/10.1186\/s13046-016-0310-6","journal-title":"J Exp Clin Cancer Res"},{"key":"12769_CR9","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/j.bbamcr.2016.03.007","volume":"1863","author":"F Palmieri","year":"2016","unstructured":"Palmieri F, Monn\u00e9 M (2016) Discoveries, metabolic roles and diseases of mitochondrial carriers: a review. Biochim Biophys Acta 1863:2362\u20132378. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.03.007","journal-title":"Biochim Biophys Acta"},{"key":"12769_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/cancers15020411","volume":"15","author":"G Lauria","year":"2023","unstructured":"Lauria G, Curcio R, Lunetti P, Tiziani S, Coppola V, Dolce V, Fiermonte G, Ahmed A (2023) Role of mitochondrial transporters on metabolic rewiring of pancreatic adenocarcinoma: a comprehensive review. Cancers 15:411. https:\/\/doi.org\/10.3390\/cancers15020411","journal-title":"Cancers"},{"issue":"9","key":"12769_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/cimb47090751","volume":"47","author":"YH Sun","year":"2025","unstructured":"Sun YH, Zhang JX, Jin HS, Huang J (2025) Crosstalk between metabolic reprogramming and epigenetic modifications in colorectal cancer: mechanisms and clinical applications. Curr Issues Mol Biol 47(9):751. https:\/\/doi.org\/10.3390\/cimb47090751","journal-title":"Curr Issues Mol Biol"},{"key":"12769_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metabol 23:27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metabol"},{"key":"12769_CR13","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.1021\/acs.chemrev.7b00775","volume":"118","author":"JL Counihan","year":"2018","unstructured":"Counihan JL, Grossman EA, Nomura DK (2018) Cancer metabolism: current understanding and therapies. Chem Rev 118:6893\u20136923. https:\/\/doi.org\/10.1021\/acs.chemrev.7b00775","journal-title":"Chem Rev"},{"key":"12769_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41422-018-0008-8","volume":"28","author":"S Wang","year":"2018","unstructured":"Wang S, Peng Z, Wang S, Yang L, Chen Y, Kong X, Song S, Pei P, Tian C, Yan H, Ding P (2018) KRAB-type zinc-finger proteins PITA and PISA specifically regulate p53-dependent glycolysis and mitochondrial respiration. Cell Res 28:572\u2013592. https:\/\/doi.org\/10.1038\/s41422-018-0008-8","journal-title":"Cell Res"},{"key":"12769_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12551-015-0186-2","volume":"8","author":"AM Navale","year":"2016","unstructured":"Navale AM, Paranjape AN (2016) Glucose transporters: physiological and pathological roles. Biophys Rev 8:5\u20139. https:\/\/doi.org\/10.1007\/s12551-015-0186-2","journal-title":"Biophys Rev"},{"key":"12769_CR16","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3390\/biomedicines10081837","volume":"10","author":"MY Song","year":"2022","unstructured":"Song MY, Lee DY, Yun SM, Kim EH (2022) GLUT3 Promotes Epithelial-Mesenchymal Transition via TGF-\u03b2\/JNK\/ATF2 Signaling Pathway in Colorectal Cancer Cells. Biomedicines 10:1837. https:\/\/doi.org\/10.3390\/biomedicines10081837","journal-title":"Biomedicines"},{"key":"12769_CR17","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00432-022-03960-z","volume":"148","author":"S Mizuno","year":"2022","unstructured":"Mizuno S, Seishima R, Yamasaki J, Hattori K, Ogiri M, Matsui S et al (2022) Angiopoietin-like 4 promotes glucose metabolism by regulating glucose transporter expression in colorectal cancer. J Cancer Res Clin Oncol 148:1351\u20131361. https:\/\/doi.org\/10.1007\/s00432-022-03960-z","journal-title":"J Cancer Res Clin Oncol"},{"key":"12769_CR18","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3390\/cancers12071731","volume":"12","author":"C Neitzel","year":"2020","unstructured":"Neitzel C, Demuth P, Wittmann S, Fahrer J (2020) Targeting altered energy metabolism in colorectal cancer: oncogenic reprogramming, the central role of the TCA cycle and therapeutic opportunities. Cancers 12:1731. https:\/\/doi.org\/10.3390\/cancers12071731","journal-title":"Cancers"},{"key":"12769_CR19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/1471-2407-9-432","volume":"9","author":"D Cao","year":"2009","unstructured":"Cao D, Hou M, Guan YS, Jiang M, Yang Y, Gou HF (2009) Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer 9:432. https:\/\/doi.org\/10.1186\/1471-2407-9-432","journal-title":"BMC Cancer"},{"key":"12769_CR20","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.7150\/thno.32915","volume":"9","author":"C Kuo","year":"2019","unstructured":"Kuo C, Ling H, Chiang M, Chung C, Lee W, Chu C et al (2019) Metastatic colorectal cancer rewrites metabolic program through a Glut3-YAP-dependent signalling circuit. Theranostics 9:2526\u20132540. https:\/\/doi.org\/10.7150\/thno.32915","journal-title":"Theranostics"},{"key":"12769_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12864-018-4477-4","volume":"19","author":"E Pudova","year":"2018","unstructured":"Pudova E, Kudryavtseva A, Fedorova M, Zaretsky A, Shcherbo D, Lukyanova E et al (2018) HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer. BMC Genom 19:113. https:\/\/doi.org\/10.1186\/s12864-018-4477-4","journal-title":"BMC Genom"},{"key":"12769_CR22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bbrc.2018.02.123","volume":"497","author":"F Ye","year":"2018","unstructured":"Ye F, Chen Y, Xia L, Lian J, Yang S (2018) Aldolase A overexpression is associated with poor prognosis and promotes tumor progression by the epithelial-mesenchymal transition in colon cancer. Biochem Biophys Res Commun 497:639\u2013645. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.123","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"12769_CR23","doi-asserted-by":"publisher","first-page":"20543","DOI":"10.18632\/oncotarget.16129","volume":"8","author":"MD Cruz","year":"2017","unstructured":"Cruz MD, Ledbetter S, Chowdhury S, Tiwari AK, Momi N, Wali RK, Bliss C, Huang C, Lichtenstein D, Bhattacharya S, Varma-Wilson A, Backman V, Roy HK (2017) Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis. Oncotarget 8(13):20543\u201320557. https:\/\/doi.org\/10.18632\/oncotarget.16129","journal-title":"Oncotarget"},{"issue":"11","key":"12769_CR24","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.3390\/cancers12113244","volume":"12","author":"R P\u00e9rez-Tom\u00e1s","year":"2020","unstructured":"P\u00e9rez-Tom\u00e1s R, P\u00e9rez-Guill\u00e9n I (2020) Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. Cancers (Basel) 12(11):3244. https:\/\/doi.org\/10.3390\/cancers12113244","journal-title":"Cancers (Basel)"},{"key":"12769_CR25","doi-asserted-by":"publisher","first-page":"102156","DOI":"10.1016\/j.tranon.2024.102156","volume":"50","author":"R Qin","year":"2024","unstructured":"Qin R, Fan X, Huang Y, Chen S, Ding R, Yao Y, Wu R, Duan Y, Li X, Khan HU, Hu J, Wang H (2024) Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance. Transl Oncol 50:102156. https:\/\/doi.org\/10.1016\/j.tranon.2024.102156","journal-title":"Transl Oncol"},{"key":"12769_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jons.2017.06.002","volume":"3","author":"A Fadaka","year":"2017","unstructured":"Fadaka A, Ajiboye B, Ojo O, Adewale O, Olayide I, Emuowhochere R (2017) Biology of glucose metabolization in cancer cells. J Oncol Sci 3:45\u201351. https:\/\/doi.org\/10.1016\/j.jons.2017.06.002","journal-title":"J Oncol Sci"},{"key":"12769_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.gde.2016.05.003","volume":"38","author":"AJ Rauckhorst","year":"2016","unstructured":"Rauckhorst AJ, Taylor EB (2016) Mitochondrial pyruvate carrier function and cancer metabolism. Curr Opin Genet Dev 38:102\u2013109. https:\/\/doi.org\/10.1016\/j.gde.2016.05.003","journal-title":"Curr Opin Genet Dev"},{"key":"12769_CR28","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3390\/biom10121611","volume":"10","author":"G Gyimesi","year":"2020","unstructured":"Gyimesi G, Hediger MA (2020) Sequence Features of Mitochondrial Transporter Protein Families. Biomolecules 10:1611. https:\/\/doi.org\/10.3390\/biom10121611","journal-title":"Biomolecules"},{"key":"12769_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/BJ20141171","volume":"466","author":"KS McCommis","year":"2015","unstructured":"McCommis KS, Finck BN (2015) Mitochondrial pyruvate transport: A historical perspective and future research directions. Biochem J 466:443\u2013454. https:\/\/doi.org\/10.1042\/BJ20141171","journal-title":"Biochem J"},{"key":"12769_CR30","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1038\/s41598-018-21740-z","volume":"8","author":"RSK Nagampalli","year":"2018","unstructured":"Nagampalli RSK, Quesnay JEN, Adamoski D, Islam Z, Birch J, Sebinelli HG, Girard R, Ascencao CFR, Fala AM, Pauletti BA et al (2018) Human mitochondrial pyruvate carrier 2 as an autonomous membrane transporter. Sci Rep 8:3510. https:\/\/doi.org\/10.1038\/s41598-018-21740-z","journal-title":"Sci Rep"},{"key":"12769_CR31","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3390\/cancers11101460","volume":"11","author":"L Yan","year":"2019","unstructured":"Yan L, Raj P, Yao W, Ying H (2019) Glucose Metabolism in Pancreatic Cancer. Cancers 11:1460. https:\/\/doi.org\/10.3390\/cancers11101460","journal-title":"Cancers"},{"key":"12769_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s12935-020-01612-1","volume":"20","author":"X Chen","year":"2020","unstructured":"Chen X, Chen S, Yu D (2020) Protein kinase function of pyruvate kinase M2 and cancer. Cancer Cell Int 20:523. https:\/\/doi.org\/10.1186\/s12935-020-01612-1","journal-title":"Cancer Cell Int"},{"key":"12769_CR33","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/cancers13071488","volume":"13","author":"A Ruiz-Iglesias","year":"2021","unstructured":"Ruiz-Iglesias A, Manes S (2021) The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis. Cancers 13:1488. https:\/\/doi.org\/10.3390\/cancers13071488","journal-title":"Cancers"},{"key":"12769_CR34","doi-asserted-by":"publisher","first-page":"6618837","DOI":"10.1155\/2021\/6618837","volume":"2021","author":"M Kuerbanjiang","year":"2021","unstructured":"Kuerbanjiang M, Gu L, Xu C, Xu WT, Wen S, Xue H, Xu Q (2021) Decreased Expression of MPC2 Contributes to Aerobic Glycolysis and Colorectal Cancer Proliferation by Activating mTOR Pathway. J Immunol Res 2021:6618837. https:\/\/doi.org\/10.1155\/2021\/6618837","journal-title":"J Immunol Res"},{"key":"12769_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.cmet.2019.11.002","volume":"31","author":"CL Bensard","year":"2020","unstructured":"Bensard CL, Wisidagama DR, Olson KA, Berg JA, Krah NM, Schell JC, Nowinski SM, Fogarty S, Bott AJ, Wei P et al (2020) Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier. Cell Metab 31:284\u2013300e287. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.002","journal-title":"Cell Metab"},{"key":"12769_CR36","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/cas.13980","volume":"110","author":"Y Takaoka","year":"2019","unstructured":"Takaoka Y, Konno M, Koseki J, Colvin H, Asai A, Tamari K, Satoh T, Mori M, Doki Y, Ogawa K et al (2019) Mitochondrial pyruvate carrier 1 expression controls cancer epithelial-mesenchymal transition and radioresistance. Cancer Sci 110:1331\u20131339. https:\/\/doi.org\/10.1111\/cas.13980","journal-title":"Cancer Sci"},{"key":"12769_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","volume":"56","author":"JC Schell","year":"2014","unstructured":"Schell JC, Olson KA, Jiang L, Hawkins AJ, Van Vranken JG, Xie J, Egnatchik RA, Earl EG, DeBerardinis RJ, Rutter J (2014) A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell 56:400\u2013413. https:\/\/doi.org\/10.1016\/j.molcel.2014.09.026","journal-title":"Mol Cell"},{"key":"12769_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.redox.2018.10.024","volume":"20","author":"Y Tai","year":"2019","unstructured":"Tai Y, Cao F, Li M, Li P, Xu T, Wang X, Yu Y, Gu B, Yu X, Cai X et al (2019) Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-gamma in colon cancer. Redox Biol 20:451\u2013457. https:\/\/doi.org\/10.1016\/j.redox.2018.10.024","journal-title":"Redox Biol"},{"issue":"1","key":"12769_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00018-025-05881-9","volume":"82","author":"B Zhang","year":"2025","unstructured":"Zhang B, Xu A, Wang H, Yan W, Zhang Q, Wang S (2025) MPC-mediated lactate production drives histone lactylation in dendritic cells to affect tumor progression and immunotherapy. Cell Mol Life Sci 82(1):371. https:\/\/doi.org\/10.1007\/s00018-025-05881-9","journal-title":"Cell Mol Life Sci"},{"key":"12769_CR40","doi-asserted-by":"publisher","first-page":"1089918","DOI":"10.3389\/fendo.2022.1089918","volume":"13","author":"Q Sun","year":"2023","unstructured":"Sun Q, Wu J, Zhu G, Li T, Zhu X, Ni B, Xu B, Ma X, Li J (2023) Lactate-related metabolic reprogramming and immune regulation in colorectal cancer. Front Endocrinol 13:1089918. https:\/\/doi.org\/10.3389\/fendo.2022.1089918","journal-title":"Front Endocrinol"},{"issue":"3","key":"12769_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41419-019-1324-8","volume":"920190","author":"H Zou","year":"2019","unstructured":"Zou H, Chen Q, Zhang A, Wang S, Wu H, Yuan Y, Wang S, Yu J, Luo M, Wen X, Cui W, Fu W, Yu R, Chen L, Zhang M, Lan H, Zhang X, Xie Q, Jin G, Xu C (2019) MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway. Cell Death Dis 920190(3):148. https:\/\/doi.org\/10.1038\/s41419-019-1324-8 PMID: 30770798; PMCID: PMC6377639","journal-title":"Cell Death Dis"},{"key":"12769_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41419-018-0494-0","volume":"9","author":"D Li","year":"2018","unstructured":"Li D, Wang C, Ma P et al (2018) PGC1\u03b1 promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect. Cell Death Dis 9:466. https:\/\/doi.org\/10.1038\/s41419-018-0494-0","journal-title":"Cell Death Dis"},{"key":"12769_CR43","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.3390\/ijms22126587","volume":"22","author":"P Icard","year":"2021","unstructured":"Icard P, Coquerel A, Wu Z, Gligorov J, Fuks D, Fournel L, Lincet H, Simula L (2021) Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update. Int J Mol Sci 22:6587. https:\/\/doi.org\/10.3390\/ijms22126587","journal-title":"Int J Mol Sci"},{"key":"12769_CR44","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10555-021-10007-1","volume":"40","author":"EK Parkinson","year":"2021","unstructured":"Parkinson EK, Adamski J, Zahn G, Gaumann A, Flores-Borja F, Ziegler C, Mycielska ME (2021) Extracellular citrate and metabolic adaptations of cancer cells. Cancer Metastasis Rev 40:1073\u20131091. https:\/\/doi.org\/10.1007\/s10555-021-10007-1","journal-title":"Cancer Metastasis Rev"},{"key":"12769_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/biom11020141","volume":"11","author":"R Mosaoa","year":"2021","unstructured":"Mosaoa R, Kasprzyk-Pawelec A, Fernandez HR, Avantaggiati ML (2021) The Mitochondrial Citrate Carrier SLC25A1\/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond. Biomolecules 11:141. https:\/\/doi.org\/10.3390\/biom11020141","journal-title":"Biomolecules"},{"key":"12769_CR46","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00018-022-04466-0","volume":"79","author":"V Zara","year":"2022","unstructured":"Zara V, Assalve G, Ferramosca A (2022) Multiple roles played by the mitochondrial citrate carrier in cellular metabolism and physiology. Cell Mol Life Sci 79:428. https:\/\/doi.org\/10.1007\/s00018-022-04466-0","journal-title":"Cell Mol Life Sci"},{"key":"12769_CR47","doi-asserted-by":"publisher","first-page":"1081262","DOI":"10.3389\/fgene.2022.1081262","volume":"13","author":"F Liu","year":"2022","unstructured":"Liu F, Deng S, Li Y, Du J, Zeng H (2022) SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients. Front Genet 13:1081262. https:\/\/doi.org\/10.3389\/fgene.2022.1081262","journal-title":"Front Genet"},{"key":"12769_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12672-023-00830-z","volume":"14","author":"X You","year":"2023","unstructured":"You X, Huang L, Huang O, Deng Y, Shi X (2023) A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancer. Discov Oncol 14:207. https:\/\/doi.org\/10.1007\/s12672-023-00830-z","journal-title":"Discov Oncol"},{"key":"12769_CR49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fonc.2018.00170","volume":"8","author":"J Hlouschek","year":"2018","unstructured":"Hlouschek J, Hansel C, Jendrossek V, Matschke J (2018) The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells with Tolerance to Cycling Severe Hypoxia. Front Oncol 8:170. https:\/\/doi.org\/10.3389\/fonc.2018.00170","journal-title":"Front Oncol"},{"key":"12769_CR50","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41418-018-0101-z","volume":"25","author":"HR Fernandez","year":"2018","unstructured":"Fernandez HR, Gadre SM, Tan M, Graham GT, Mosaoa R, Ongkeko MS, Kim KA, Riggins RB, Parasido E, Petrini I et al (2018) The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer. Cell Death Differ 25:1239\u20131258. https:\/\/doi.org\/10.1038\/s41418-018-0101-z","journal-title":"Cell Death Differ"},{"key":"12769_CR51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2017.05.002","volume":"401","author":"Q Liu","year":"2017","unstructured":"Liu Q, Luo Q, Halim A, Song G (2017) Targeting lipid metabolism of cancer cells: a promising therapeutic strategy for cancer. Cancer Lett 401:39\u201345. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.002","journal-title":"Cancer Lett"},{"key":"12769_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G (2020) Reprogramming of fatty acid metabolism in cancer. Br J cancer 122:4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z","journal-title":"Br J cancer"},{"issue":"17","key":"12769_CR53","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.3390\/molecules25173935","volume":"25","author":"CW Fhu","year":"2020","unstructured":"Fhu CW, Ali A (2020) Fatty acid synthase: an emerging target in cancer. Molecules 25(17):3935. https:\/\/doi.org\/10.3390\/molecules25173935","journal-title":"Molecules"},{"key":"12769_CR54","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","volume":"435","author":"Y Ma","year":"2018","unstructured":"Ma Y, Temkin SM, Hawkridge AM, Guo C, Wang W, Wang XY et al (2018) Fatty acid oxidation: an emerging facet of metabolic transformation in cancer. Cancer Lett 435:92\u2013100. https:\/\/doi.org\/10.1016\/j.canlet.2018.08.006","journal-title":"Cancer Lett"},{"key":"12769_CR55","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia S, Vasseur S, Guillaumond F (2016) Lipid metabolic reprogramming in cancer cells. Oncogenesis 5:e189. https:\/\/doi.org\/10.1038\/oncsis.2015.49","journal-title":"Oncogenesis"},{"key":"12769_CR56","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3389\/fonc.2020.00981","volume":"10","author":"Z Long","year":"2020","unstructured":"Long Z, Zhou J, Xie K, Wu Z, Yin H, Daria V, Tian J, Zhang N, Li L, Zhao Y et al (2020) Metabolomic Markers of Colorectal Tumor with Different Clinicopathological Features. Front Oncol 10:981. https:\/\/doi.org\/10.3389\/fonc.2020.00981","journal-title":"Front Oncol"},{"key":"12769_CR57","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.stem.2017.12.017","volume":"22","author":"B Wang","year":"2018","unstructured":"Wang B et al (2018) Phospholipid remodeling and cholesterol availability regulate intestinal stemness and tumorigenesis. Cell Stem Cell 22:206\u2013220e4. https:\/\/doi.org\/10.1016\/j.stem.2017.12.017","journal-title":"Cell Stem Cell"},{"key":"12769_CR58","first-page":"219","volume":"9","author":"X Ding","year":"2019","unstructured":"Ding X, Zhang W, Li S, Yang H (2019) The role of cholesterol metabolism in cancer. Am J Cancer Res 9:219\u2013227","journal-title":"Am J Cancer Res"},{"key":"12769_CR59","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/1878-0261.12367","volume":"12","author":"C Aguirre-Portol\u00e9s","year":"2018","unstructured":"Aguirre-Portol\u00e9s C, Feliu J, Reglero G, De Molina AR (2018) ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumor growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone. Mol Oncol 12:1735\u20131752. https:\/\/doi.org\/10.1002\/1878-0261.12367","journal-title":"Mol Oncol"},{"issue":"12","key":"12769_CR60","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41419-021-04411-2","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang Y, He J, Zhang B, Zhang Z, Jia G, Liu S, Wu T, He X, Wang N (2021) SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer. Cell Death Dis 12(12):1108. https:\/\/doi.org\/10.1038\/s41419-021-04411-2","journal-title":"Cell Death Dis"},{"key":"12769_CR61","doi-asserted-by":"publisher","first-page":"6888","DOI":"10.1158\/0008-5472.can-11-1011","volume":"71","author":"K Bhalla","year":"2011","unstructured":"Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel W, Fang HB, Vafai SB, Vazquez F, Puigserver P, Boros L et al (2011) PGC1 Promotes Tumor Growth by Inducing Gene Expression Programs Supporting Lipogenesis. Cancer Res 71:6888\u20136898. https:\/\/doi.org\/10.1158\/0008-5472.can-11-1011","journal-title":"Cancer Res"},{"key":"12769_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-017-0638-8","volume":"16","author":"M Ebadi","year":"2017","unstructured":"Ebadi M, Field CJ, Lehner R, Mazurak V (2017) Chemotherapy diminishes lipid storage capacity of adipose tissue in a preclinical model of colon cancer. Lipids Health Dis 16:1\u201312. https:\/\/doi.org\/10.1186\/s12944-017-0638-8","journal-title":"Lipids Health Dis"},{"key":"12769_CR63","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin J, Byun JK, Choi YK, Park KG (2023) Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp Mol Med 55:706\u2013715. https:\/\/doi.org\/10.1038\/s12276-023-00971-9","journal-title":"Exp Mol Med"},{"key":"12769_CR64","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.bbrc.2014.11.105","volume":"456","author":"T Pan","year":"2015","unstructured":"Pan T, Gao L, Wu G, Shen G, Xie S, Wen H, Yang J, Zhou Y, Tu Z, Qian W (2015) Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer. Biochem Biophys Res Commun 456:452\u2013458. https:\/\/doi.org\/10.1016\/j.bbrc.2014.11.105","journal-title":"Biochem Biophys Res Commun"},{"key":"12769_CR65","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","volume":"13","author":"MI Gross","year":"2014","unstructured":"Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J et al (2014) Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther 13:890\u2013901. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0870","journal-title":"Mol Cancer Ther"},{"key":"12769_CR66","first-page":"1093","volume":"7","author":"F Huang","year":"2014","unstructured":"Huang F, Zhang Q, Ma H, Lv Q, Zhang T (2014) Expression of glutaminase is upregulated in colorectal cancer and of clinical significance. Int J Clin Exp Pathol 7:1093\u20131100","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"12769_CR67","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.3892\/ol.2017.6538","volume":"14","author":"Z Song","year":"2017","unstructured":"Song Z, Wei B, Lu C, Li P, Chen L (2017) Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer. Oncol Lett 14(3):3117\u20133123. https:\/\/doi.org\/10.3892\/ol.2017.6538","journal-title":"Oncol Lett"},{"key":"12769_CR68","doi-asserted-by":"publisher","first-page":"11971","DOI":"10.1038\/ncomms11971","volume":"7","author":"Y Hao","year":"2016","unstructured":"Hao Y et al (2016) Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer. Nat Commun 7:11971. https:\/\/doi.org\/10.1038\/ncomms11971","journal-title":"Nat Commun"},{"key":"12769_CR69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fchem.2014.00061","volume":"2","author":"L Pochini","year":"2014","unstructured":"Pochini L, Scalise M, Galluccio M, Indiveri C (2014) Membrane transporters for the special amino acid glutamine: structure\/function relationships and relevance to human health. Front Chem 2:61. https:\/\/doi.org\/10.3389\/fchem.2014.00061","journal-title":"Front Chem"},{"key":"12769_CR70","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fonc.2017.00306","volume":"7","author":"M Scalise","year":"2017","unstructured":"Scalise M, Pochini L, Galluccio M, Console L, Indiveri C (2017) Glutamine transport and mitochondrial metabolism in cancer cell growth Front. Oncol 7:306. https:\/\/doi.org\/10.3389\/fonc.2017.00306","journal-title":"Oncol"},{"key":"12769_CR71","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","volume":"31","author":"HC Yoo","year":"2019","unstructured":"Yoo HC, Park SJ, Nam M, Kang J, Kim K, Yeo JH, Kim JK, Heo Y, Lee HS, Lee MY, Lee CW, Kang JS, Kim YH, Lee J, Choi J, Hwang GS, Bang S, Han JM (2019) A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells. Cell Metab 31:267\u2013283e12. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.020","journal-title":"Cell Metab"},{"issue":"1","key":"12769_CR72","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40170-026-00421-w","volume":"14","author":"PJ Dalal","year":"2026","unstructured":"Dalal PJ, Singhal R, Hu B, Stark D, Rossiter NJ, Jain C, Sajjakulnukit P, Lyssiotis CA, Shah YM (2026) Targeting HIF-2\u03b1 in colorectal cancer reveals a cholesterol biosynthesis-dependent ferroptotic vulnerability. Cancer Metab 14(1):5. https:\/\/doi.org\/10.1186\/s40170-026-00421-w","journal-title":"Cancer Metab"},{"key":"12769_CR73","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.4155\/fmc.13.130","volume":"5","author":"MJ Lukey","year":"2013","unstructured":"Lukey MJ, Wilson KF, Cerne RA (2013) Therapeutic strategies impacting cancer cell glutamine metabolism. Future Med Chem 5:1685\u20131700. https:\/\/doi.org\/10.4155\/fmc.13.130","journal-title":"Future Med Chem"},{"key":"12769_CR74","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3390\/antiox9111151","volume":"9","author":"M Jaganjac","year":"2020","unstructured":"Jaganjac M, Milkovic L, Sunjic SB, Zarkovic N (2020) The NRF2, thioredoxin, and glutathione system in tumorigenesis and anticancer therapies. Antioxidants 9:1151. https:\/\/doi.org\/10.3390\/antiox9111151","journal-title":"Antioxidants"},{"key":"12769_CR75","doi-asserted-by":"publisher","first-page":"102065","DOI":"10.1016\/j.redox.2021.102065","volume":"46","author":"M Ying","year":"2021","unstructured":"Ying M, You D, Zhu X, Cai L, Zeng S, Hu X (2021) Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions. Redox Biol 46:102065. https:\/\/doi.org\/10.1016\/j.redox.2021.102065","journal-title":"Redox Biol"},{"key":"12769_CR76","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","volume":"80","author":"JK Byun","year":"2020","unstructured":"Byun JK, Park M, Lee S, Yun JW, Lee J, Kim JS, Cho SJ, Jeon HJ, Lee IK, Choi YK, Park KG (2020) Inhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor Immunity. Mol Cell 80:592\u2013606e8. https:\/\/doi.org\/10.1016\/j.molcel.2020.10.015","journal-title":"Mol Cell"},{"key":"12769_CR77","doi-asserted-by":"publisher","first-page":"101753","DOI":"10.1016\/j.jbc.2022.101753","volume":"298","author":"Q Li","year":"2022","unstructured":"Li Q, Zhong X, Yao W, Yu J, Wang C, Li Z et al (2022) Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity. J Biol Chem 298:101753. https:\/\/doi.org\/10.1016\/j.jbc.2022.101753","journal-title":"J Biol Chem"},{"key":"12769_CR78","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12964-025-02504-5","volume":"23","author":"Y Xu","year":"2025","unstructured":"Xu Y, Wang J, Wu A, Wang M (2025) Ammonia metabolism and ammonia-induced cell death: role in cancer therapy. Cell Commun Signal 23:468. https:\/\/doi.org\/10.1186\/s12964-025-02504-5","journal-title":"Cell Commun Signal"},{"key":"12769_CR79","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.celrep.2016.09.045","volume":"17","author":"B Smith","year":"2016","unstructured":"Smith B et al (2016) Addiction to coupling of the Warburg effect with glutamine catabolism in cancer cells. Cell Rep 17:821\u2013836. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.045","journal-title":"Cell Rep"},{"key":"12769_CR80","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41556-019-0408-0","volume":"21","author":"S Schmidt","year":"2019","unstructured":"Schmidt S et al (2019) A MYC-GCN2-eIF2\u03b1 negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer. Nat Cell Biol 21:1413\u20131424. https:\/\/doi.org\/10.1038\/s41556-019-0408-0","journal-title":"Nat Cell Biol"},{"key":"12769_CR81","doi-asserted-by":"publisher","first-page":"910","DOI":"10.4103\/1735-1995.170634","volume":"20","author":"NR Jolfaie","year":"2015","unstructured":"Jolfaie NR, Mirzaie S, Ghiasvand R, Askari G, Miraghajani M (2015) The effect of glutamine intake on complications of colorectal and colon cancer treatment: A systematic review. J Res Med Sci 20:910\u2013918. https:\/\/doi.org\/10.4103\/1735-1995.170634","journal-title":"J Res Med Sci"},{"issue":"19","key":"12769_CR82","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1038\/s41388-020-01639-8","volume":"40","author":"J Eniafe","year":"2021","unstructured":"Eniafe J, Jiang S (2021) The functional roles of TCA cycle metabolites in cancer. Oncogene 40(19):3351\u20133363. https:\/\/doi.org\/10.1038\/s41388-020-01639-8","journal-title":"Oncogene"},{"key":"12769_CR83","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1186\/1471-2407-14-891","volume":"14","author":"AL Silva","year":"2014","unstructured":"Silva AL, Dawson SN, Arends MJ, Guttula K, Hall N, Cameron EA, Huang TH, Brenton JD, Tavar\u00e9 S, Bienz M, Ibrahim AE (2014) Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signalling antagonists. BMC Cancer 14:891. https:\/\/doi.org\/10.1186\/1471-2407-14-891","journal-title":"BMC Cancer"},{"issue":"2","key":"12769_CR84","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11626-024-00998-w","volume":"61","author":"H Yang","year":"2025","unstructured":"Yang H, Han Z, Yang Y, Zhou S, Zhang B, He J, He X, Wang N (2025) Expression, prognosis, immunological infiltration, and DNA methylation of members of the SFRP gene family in colorectal cancer: a comparative bioinformatic and experimental analysis. Vitro Cell Dev Biol Anim 61(2):149\u2013164. https:\/\/doi.org\/10.1007\/s11626-024-00998-w","journal-title":"Vitro Cell Dev Biol Anim"},{"issue":"1","key":"12769_CR85","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12967-024-05329-x","volume":"22","author":"H Boughanem","year":"2024","unstructured":"Boughanem H, Pilo J, Garc\u00eda-Flores LA, Arranz I, Ramos-Fernandez M, Ortega-Castan M, Crujeiras AB, Sandoval J, Macias-Gonzalez M (2024) Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance. J Transl Med 22(1):509. https:\/\/doi.org\/10.1186\/s12967-024-05329-x","journal-title":"J Transl Med"},{"issue":"1","key":"12769_CR86","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00018-025-05881-9","volume":"28","author":"B Zhang","year":"2025","unstructured":"Zhang B, Xu A, Wang H, Yan W, Zhang Q, Wang S (2025) MPC-mediated lactate production drives histone lactylation in dendritic cells to affect tumor progression and immunotherapy. Cell Mol Life Sci Oct 28(1):371. https:\/\/doi.org\/10.1007\/s00018-025-05881-9","journal-title":"Cell Mol Life Sci Oct"},{"issue":"1","key":"12769_CR87","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-025-07498-z","volume":"16","author":"J Deng","year":"2025","unstructured":"Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, Mu L, Luo X, Qin J (2025) Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis 16(1):193. https:\/\/doi.org\/10.1038\/s41419-025-07498-z","journal-title":"Cell Death Dis"},{"issue":"4","key":"12769_CR88","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s12253-019-00663-8","volume":"26","author":"J Qin","year":"2020","unstructured":"Qin J, Wen B, Liang Y, Yu W, Li H (2020) Histone Modifications and their Role in Colorectal Cancer (Review). Pathol Oncol Res 26(4):2023\u20132033. https:\/\/doi.org\/10.1007\/s12253-019-00663-8","journal-title":"Pathol Oncol Res"},{"key":"12769_CR89","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12967-022-03525-1","volume":"20","author":"L Zhang","year":"2022","unstructured":"Zhang L, Ren CF, Yang Z et al (2022) Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt\/\u03b2-catenin signalling pathway to regulate colorectal cancer progression. J Transl Med 20:327. https:\/\/doi.org\/10.1186\/s12967-022-03525-1","journal-title":"J Transl Med"},{"key":"12769_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-025-00369-5","author":"W Li","year":"2025","unstructured":"Li W, Han J, Huang B, Xu T, Wan Y, Luo D, Kong W, Yu Y, Zhang L, Nian Y, Chu B, Yin C (2025) SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate ferroptosis susceptibility via FSP1 acetylation. EMBO J. https:\/\/doi.org\/10.1038\/s44318-025-00369-5","journal-title":"EMBO J"},{"issue":"3","key":"12769_CR91","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s43018-020-0035-5","volume":"1","author":"TQ Tran","year":"2020","unstructured":"Tran TQ, Hanse EA, Habowski AN, Li H, Ishak Gabra MB, Yang Y, Lowman XH, Ooi AM, Liao SY, Edwards RA, Waterman ML, Kong M (2020) \u03b1-Ketoglutarate attenuates Wnt signalling and drives differentiation in colorectal cancer. Nat Cancer 1(3):345\u2013358. https:\/\/doi.org\/10.1038\/s43018-020-0035-5","journal-title":"Nat Cancer"},{"issue":"2","key":"12769_CR92","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cmet.2015.06.023","volume":"22","author":"AM Intlekofer","year":"2015","unstructured":"Intlekofer AM, Dematteo RG, Venneti S, Finley LW, Lu C, Judkins AR, Rustenburg AS, Grinaway PB, Chodera JD, Cross JR, Thompson CB (2015) Hypoxia Induces Production of L-2-Hydroxyglutarate. Cell Metab 22(2):304\u2013311. https:\/\/doi.org\/10.1016\/j.cmet.2015.06.023","journal-title":"Cell Metab"},{"issue":"2","key":"12769_CR93","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41575-019-0230-y","volume":"17","author":"G Jung","year":"2020","unstructured":"Jung G, Hern\u00e1ndez-Ill\u00e1n E, Moreira L, Balaguer F, Goel A (2020) Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol 17(2):111\u2013130. https:\/\/doi.org\/10.1038\/s41575-019-0230-y","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12769-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:06:16Z","timestamp":1789736776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12769-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12769"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12769-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1595"}}